J&J's potential 'game-changer' drug

Key Points:

• Stocks rose broadly on Monday as the AI sector rebounded, boosted by major news including Meta Platforms' plan to raise $95 billion in equity, SpaceX's $40 billion debt raise for Nvidia GPU purchases, and Anthropic's IPO filing.
• Investors rotated back into AI infrastructure stocks while taking profits in defensive sectors like staples, healthcare, and utilities, with upcoming hyperscaler earnings expected to shed light on AI spending and demand.
• Johnson & Johnson shares gained after announcing promising Phase 1 prostate cancer trial results for its oral drug JNJ-6143, which showed a 75% tumor response rate among treated patients, highlighting potential advances in oncology treatment.
• Microsoft shares edged higher following news of voluntary buyouts offered to 60,000 employees, seen as a strategic move to optimize operations amid ongoing AI infrastructure investments, contrasting with recent layoffs at other tech giants.
• Key earnings reports from companies including Boeing, Coca-Cola, UPS, and Johnson Controls are expected this week, alongside economic data releases such as durable goods orders, consumer confidence, and new home sales.